University of Plymouth trial to treat long Covid symptoms

University of Plymouth trial to treat long Covid symptoms

More than 70 people are taking part in the trial which will look to alleviate symptoms.

DMZ – RESEARCH ¦ Sarah Koller ¦ A recent study carried out under the US RECOVER programme suggests that the diabetes drug metformin could play a key role in reducing the risk of Long COVID in people with type 2 diabetes. This opens up new perspectives for the treatment of COVID-19 and the protection of risk groups against long-term health consequences. Background of the study Long COVID, also known as postacute sequelae of SARS-CoV-2 (PASC), aff…

Too Much Exertion Produces Autonomic Nervous System Hit in Long COVID, ME/CFS, and Fibromyalgia - Health Rising

Geoff’s Narrations The GIST The Blog   A trip to Seattle to see Dr. Ruhoy held up the blogs a bit but they’re back! Exercise physiologist Rob Wust’s “Wearable heart rate variability monitoring identifies autonomic dysfunction and thresholds for post-exertional malaise in Long COVID” study did something simple but important: […]